| 00:00:00 | When size is not enough! |
| 00:02:02 | When size is not enough! |
| 00:03:38 | When size is not enough! |
| 00:05:13 | Outline |
| 00:06:35 | Particle shape analysis for pharmaceuticals |
| 00:07:37 | Shape analysis with automated optical imaging |
| 00:08:23 | Particle chemical analysis for pharmaceuticals |
| 00:09:34 | Raman spectroscopy coupled with automated optical imaging |
| 00:10:26 | Drug delivery |
| 00:10:52 | Case study – characterization of drug delivery polymer microspheres with automated optical imaging |
| 00:12:22 | Case study – characterization of drug delivery polymer microspheres with automated optical imaging |
| 00:13:09 | Characterization of drug delivery polymermicrospheres using the Morphologi® G3SE |
| 00:14:38 | Characterization of drug delivery polymermicrospheres using the Morphologi® G3SE |
| 00:15:54 | Automation of QC analysis for pharmaceutical ointments |
| 00:16:26 | Case study – Automation of QC analysis for pharmaceutical ointments |
| 00:17:47 | Case study – Automation of QC analysis for pharmaceutical ointments |
| 00:19:37 | Automation of QC analysis for nasal drugs |
| 00:20:34 | Case study – Automation of QC analysis for nasal drugs |
| 00:21:44 | Case study – Automation of QC analysis for nasal drugs |
| 00:22:58 | Automation of Manual QC analysis ofNasal Spray on the Morphologi® G3 |
| 00:24:59 | Automation of Manual QC analysis ofNasal Spray on the Morphologi® G3 |
| 00:26:36 | Allergen characterization |
| 00:26:56 | Case study – Allergen Characterization |
| 00:27:58 | Case study – Allergen Characterization |
| 00:29:02 | Characterization of pollen samples withthe Morphologi® G3SE – A case study |
| 00:30:15 | Characterization of pollen samples withthe Morphologi® G3SE – A case study |
| 00:32:47 | Size and shape of active pharmaceutical ingredients in concentrated suspensions and emulsions |
| 00:33:13 | Case study – size and shape analysis of API in concentrated suspensions and emulsions |
| 00:33:26 | Case study – size and shape analysis of API in concentrated suspensions and emulsions |
| 00:35:17 | Automated analysis of crystals in suspension |
| 00:37:09 | In-Vitro Bioequivalence Study with the automated image analysis coupled with Raman spectroscopy |
| 00:38:30 | In-Vitro Bioequivalence Study with the G3-ID |
| 00:39:29 | In-Vitro Bioequivalence Study with the G3-ID |
| 00:40:24 | In-Vitro Bioequivalence Study with the G3-ID |
| 00:41:55 | In-Vitro Bioequivalence Study with the G3-ID |
| 00:44:46 | In-Vitro Bioequivalence Study with the G3-ID |
| 00:46:33 | Other applications of G3-ID |
| 00:47:17 | Summary |
| 00:48:07 | Contact Information |
Particle size has been recognized as a key parameter in the development and manufacture of a wide range of pharmaceutical materials. Sometimes, however, size analysis is just not enough to provide the answer to a specific application issue. This presentation describes the advantages of investigating not only the size but also the shape and chemical signature of various products and formulations. The talk is application based, which means that it doesn't focus on how and what we can measure, but instead on how we can use the information on shape and chemistry to directly influence product performance.